Colour theme
Theme
Sign in
Insider · CIK 0001337143

Sieger Markus

CIK 0001337143 Name as filed on the most recent filing

Filed as Sieger Markus (15)

20 transaction lines · from 15 filings · filed 2009-06-01 to 2023-04-24 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

20 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2023-04-20 Cyclo Therapeutics, Inc.
CYTH
P, Open-market purchase 59,881 acquired 0.71 42,515.51 Form 4, filing 0001437749-23-010876
2022-03-29 Cyclo Therapeutics, Inc.
CYTH
P, Open-market purchase 10,000 acquired 2.73 27,300.00 Form 4, filing 0001437749-22-007616
2021-03-29 Cyclo Therapeutics, Inc.
CYTH
P, Open-market purchase 10,000 acquired 8.10 81,000.00 Form 4, filing 0001437749-21-007619
2021-01-26 Cyclo Therapeutics, Inc.
CYTH
P, Open-market purchase 2,201 acquired 6.60 14,526.60 Form 4, filing 0001437749-21-001338
2021-01-25 Cyclo Therapeutics, Inc.
CYTH
P, Open-market purchase 3,400 acquired 6.36 21,624.00 Form 4, filing 0001437749-21-001338
2021-01-25 Cyclo Therapeutics, Inc.
CYTH
P, Open-market purchase 2,999 acquired 6.20 18,593.80 Form 4, filing 0001437749-21-001338
2021-01-25 Cyclo Therapeutics, Inc.
CYTH
P, Open-market purchase 1,400 acquired 6.35 8,890.00 Form 4, filing 0001437749-21-001338
2020-12-11 Cyclo Therapeutics, Inc.
CYTH
P, Open-market purchase 15,000 acquired Not reported Not priced Form 4, filing 0001437749-20-025286
2020-08-27 Cyclo Therapeutics, Inc.
CTDH
P, Open-market purchase 750,000 acquired Not reported Not priced Form 4, filing 0001437749-20-018982
2020-04-24 Cyclo Therapeutics, Inc.
CTDH
P, Open-market purchase 500,000 acquired 0.10 50,000.00 Form 4, filing 0001437749-20-008575
2019-08-23 CTD Holdings Inc
CTDH
P, Open-market purchase 100,000 acquired 0.22 22,000.00 Form 4, filing 0001437749-19-017442
2019-05-31 CTD Holdings Inc
CTDH
P, Open-market purchase 400,000 acquired Not reported Not priced Form 4, filing 0001437749-19-011249
2018-12-21 CTD Holdings Inc
CTDH
P, Open-market purchase 100,000 acquired Not reported Not priced Form 4, filing 0001437749-18-022633
2017-02-23 CTD Holdings Inc
CTDH
P, Open-market purchase 142,857 acquired Not reported Not priced Form 4, filing 0001213900-17-001797
2014-02-19 CTD Holdings Inc
CTDH
P, Open-market purchase 3,500,000 acquired 0.05 175,000.00 Form 4, filing 0000908662-14-000078
2011-08-19 Central European Distribution Corp
CEDC
P, Open-market purchase 12,000 acquired 5.60 67,200.00 Form 4, filing 0001181431-11-046421
2011-03-07 Central European Distribution Corp
CEDC
P, Open-market purchase 2,000 acquired 12.50 25,000.00 Form 4, filing 0001181431-11-016766
2009-05-28 Central European Distribution Corp
CEDC
P, Open-market purchase 800 acquired 23.18 18,544.00 Form 4, filing 0001181431-09-027966
2009-05-28 Central European Distribution Corp
CEDC
P, Open-market purchase 100 acquired 23.15 2,315.00 Form 4, filing 0001181431-09-027966
2009-05-28 Central European Distribution Corp
CEDC
P, Open-market purchase 100 acquired 23.13 2,313.00 Form 4, filing 0001181431-09-027966

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 20
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Sieger Markus, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001337143

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.